The JAZZ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the JAZZ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The JAZZ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View JAZZ Detailed Price Forecast - CNN Money||View JAZZ Detailed Summary - Google Finance|
|View JAZZ Detailed Summary - Yahoo! Finance||View JAZZ Stock Research & Analysis - Zacks.com|
|View JAZZ Trends & Analysis - Trade-Ideas||View JAZZ Major Holders - Barrons|
|View JAZZ Call Transcripts - NASDAQ||View JAZZ Breaking News & Analysis - Seeking Alpha|
|View JAZZ Annual Report - CompanySpotlight.com||View JAZZ OTC Short Report - OTCShortReport.com|
|View JAZZ Fundamentals - TradeKing||View JAZZ SEC Filings - Bar Chart|
|View Historical Prices for JAZZ - The WSJ||View Performance/Total Return for JAZZ - Morningstar|
|View the Analyst Estimates for JAZZ - MarketWatch||View the Earnings History for JAZZ - CNBC|
|View the JAZZ Earnings - StockMarketWatch||View JAZZ Buy or Sell Recommendations - MacroAxis|
|View the JAZZ Bullish Patterns - American Bulls||View JAZZ Short Pain Metrics - ShortPainBot.com|
|View JAZZ Stock Mentions - StockTwits||View JAZZ Stock Mentions - PennyStockTweets|
|View JAZZ Stock Mentions - Twitter||View JAZZ Investment Forum News - Investor Hub|
|View JAZZ Stock Mentions - Yahoo! Message Board||View JAZZ Stock Mentions - Seeking Alpha|
|View Insider Transactions for JAZZ - SECform4.com||View Insider Transactions for JAZZ - Insider Cow|
|View JAZZ Major Holdings Summary - CNBC||View Insider Disclosure for JAZZ - OTC Markets|
|View Insider Transactions for JAZZ - Yahoo! Finance||View Institutional Holdings for JAZZ - NASDAQ|
|View JAZZ Stock Insight & Charts - FinViz.com||View JAZZ Investment Charts - StockCharts.com|
|View JAZZ Stock Overview & Charts - BarChart||View JAZZ User Generated Charts - Trading View|
The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering
Posted on Thursday March 21, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 20) AstraZeneca plc (NYSE: AZN ) BioDelivery Sciences ...
FDA approves Jazz Pharmaceuticals sleep disorder drug
Posted on Wednesday March 20, 2019
The Food and Drug Administration approved Jazz Pharmaceuticals' new drug application for Sunosi, a once-daily medicine designed to improve wakefulness in adult patients suffering from narcolepsy and obstructive sleep apnea. Sunosi is expected to be commercially available in the United States following the final scheduling decision by the U.S. Drug Enforcement Administration, which is typically rendered within 90 days of FDA approval. Jazz Pharmaceuticals, which is based in Dublin, Ireland, has major operations in Philadelphia where the company has about 160 employees.
Jazz Pharma's sleep disorder treatment gets FDA nod
Posted on Wednesday March 20, 2019
The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday. The drug, solriamfetol, will treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA). Solriamfetol is expected to be commercially available in the United States following the final scheduling decision by the Drug Enforcement Administration (DEA), Jazz said in a statement.
DUBLIN, March 20, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Sunosi™ (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). Once-daily Sunosi is approved with doses of 75 mg and 150 mg for patients with narcolepsy and doses of 37.5 mg, 75 mg, and 150 mg for patients with OSA.